| ---
|
| license: cc-by-nc-4.0
|
| pretty_name: "CSA — Clinical-Stage Asset Intelligence (Free Sample)"
|
| task_categories:
|
| - tabular-classification
|
| tags:
|
| - biotech
|
| - clinical-trials
|
| - finance
|
| - pharmaceuticals
|
| - catalyst-calendar
|
| - healthcare
|
| size_categories:
|
| - n<1K
|
| configs:
|
| - config_name: catalyst_calendar
|
| data_files: catalyst_calendar_sample.csv
|
| default: true
|
| - config_name: asset_master
|
| data_files: asset_master_sample.csv
|
| ---
|
|
|
| # CSA — Clinical-Stage Asset Intelligence · Free Sample
|
|
|
| > **Full dataset:** [csa.dataengineered.io](https://csa.dataengineered.io/) · **$499 one-time** → [Buy on Stripe](https://buy.stripe.com/dRmcN67BefzwazV2I83840d) · the same sample on [Kaggle](https://www.kaggle.com/datasets/ahtiticheamine/csa-clinical-stage-asset-intelligence-sample)
|
|
|
| **Clinical trials, FDA, and SEC — linked to the drug asset and the listed sponsor, with a
|
| forward catalyst calendar.** This is a free 150-row sample of the nearest-term
|
| catalysts; the full snapshot carries **2,103 forward catalysts** across
|
| **139 listed sponsors** and **1,841 resolved assets**.
|
|
|
| > **Data, not investment advice.** CSA is information, not a recommendation to buy, sell,
|
| > or hold any security. Estimated catalyst dates (e.g. protocol primary-completion dates)
|
| > routinely slip and are graded by confidence — verify anything material against the
|
| > `source_url` on each row.
|
|
|
| ## What's inside
|
|
|
| | File | Rows | What it is |
|
| | :-- | :-- | :-- |
|
| | `catalyst_calendar_sample.csv` | 150 | Nearest-term forward catalysts (2026-07-18 → 2027-09-01), 108 assets, 50 sponsors. |
|
| | `asset_master_sample.csv` | 464 | The asset ↔ trial ↔ sponsor ↔ ticker rows behind them. |
|
| | `*_sample.json` | — | The same tables as records-oriented JSON. |
|
|
|
| ### `catalyst_calendar_sample.csv`
|
| `event_date` · `ticker` · `asset` · `event_type` (PDUFA / READOUT / …) · `event_window`
|
| · `date_precision` · `confidence` · `source` (sec_8k / clinicaltrials) · `nct_id` · `source_url`.
|
|
|
| ### `asset_master_sample.csv`
|
| `asset` · `nct_id` · `phase` · `status` · `primary_completion` · `conditions` · `arm_role`
|
| · `sponsor_raw` · `company_name` · `ticker`.
|
|
|
| ## How it's built
|
|
|
| - **Active-moiety resolution** keys each asset to its FDA-registered UNII set (GSRS), not
|
| fuzzy names — audited to **zero cross-molecule merges**.
|
| - **Sponsor → listed ticker** through acquisitions, to the primary US listing.
|
| - **Dual-channel catalysts**: SEC 8-K disclosure text + active late-phase
|
| ClinicalTrials.gov protocol readouts. Every row carries its source.
|
|
|
| Sample scope: active, industry-sponsored, Phase 3 trials in cardiometabolic, oncology and
|
| immunology. Asset names are normalized for readability; the sample is curated to
|
| clinical-stage, single-sponsor assets.
|
|
|
| ## Sources & license
|
|
|
| All primary sources are U.S. Government / public domain: **ClinicalTrials.gov**,
|
| **openFDA**, **SEC EDGAR**, **GSRS/UNII**. This sample is released under **CC-BY-NC-4.0**
|
| (free to use and share with attribution, not to re-sell). See `SAMPLE_LICENSE.md`.
|
|
|
| ## Get the full dataset
|
|
|
| The complete, commercially-licensed snapshot (all 2,103 catalysts, CSV +
|
| JSON, monthly editions + delta feed) → **https://csa.dataengineered.io**
|
| · code: **https://github.com/CSA-pub/CSA-public** · contact: **https://csa.dataengineered.io/#contact**
|
|
|
